Plus Therapeutics Inc (PSTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2001 | 12-2000 | 09-2000 | 06-2000 | 12-1999 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | 7,476 | N/A | N/A | N/A |
| Marketable Securities | N/A | 37,008 | N/A | N/A | N/A |
| Receivables | N/A | 693 | N/A | N/A | N/A |
| Inventories | N/A | 2,278 | N/A | N/A | N/A |
| Other current assets | 0 | 882 | 0 | 0 | 0 |
| TOTAL | $N/A | $48,337 | $N/A | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | N/A | 3,691 | N/A | N/A | N/A |
| Other Non-Current Assets | 0 | 241 | 0 | 0 | 0 |
| TOTAL | $N/A | $3,932 | $N/A | $N/A | $N/A |
| Total Assets | $N/A | $52,269 | $N/A | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 1,364 | 0 | 0 | 0 |
| TOTAL | $N/A | $1,479 | $N/A | $N/A | $N/A |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $1,455 | $N/A | $N/A | $N/A |
| Total Liabilities | $N/A | $2,934 | $N/A | $N/A | $N/A |
| Shareholders' Equity | |||||
| Common Shares | N/A | 15 | N/A | N/A | N/A |
| Retained earnings | N/A | -15,892 | N/A | N/A | N/A |
| Other shareholders' equity | 0 | -2,914 | 0 | 0 | 0 |
| TOTAL | $N/A | $49,335 | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $0 | $52,269 | $0 | $0 | $0 |